A New City Rises in Downtown Columbia

The Downtown Columbia project is led by The Howard Hughes Corporation (NYSE: HHC), a prominent, publicly traded, large scale master developer specializing in planned communities. It will ultimately offer 14 million square feet of mixed-use building space on 391 acres of land. The city will feature more than 60 acres of protected, forested land, a storied outdoor amphitheater, a 27-acre lake, 6,244 residential units and 640 hotel rooms. Greg Fitchitt, president of Columbia for The Howard Hughes Corporation, says his company is heavily invested in the community. “We are continuing the vision of the Rouse Company, the city’s originator, updating and upgrading it,” he says. (I-95 Bus)

Read Full Article

Lawsuit accusing Atlas Restaurant Group of racial discrimination filed following Ouzo Bay incident

One of the area’s largest restaurant groups faces a discrimination lawsuit from a woman who says she and her son were barred from one of their restaurants on account of their race. The suit filed Monday in Baltimore City Circuit Court seeks more than $75,000 from the Atlas Restaurant Group for Marcia Grant and her 9 year-old-son for each of three alleged offenses, including violating their rights and inflicting emotional harm. (Balt Sun)

Read Full Article

Buccini/Pollin Group acquires Renaissance Baltimore Harborplace Hotel for $80M

The Buccini/Pollin Group (BPG) Wednesday announced the acquisition of the Renaissance Baltimore Harborplace Hotel for $80 million from Irvine, California-based Sunstone Hotel Investors Inc., further expanding BPG’s portfolio of Marriott-affiliated and lifestyle hotels. Sunstone President and CEO John Arabia said the sale further concentrates its portfolio into long-term relevant real estate and increases the company’s liquidity. (Daily Record)

Read Full Article

Maryland company, 2 partners, get $34.6M to fight COVID-19

A Gaithersburg-based global life sciences company announced Wednesday it will partner with two other organizations to work on a preventative COVID-19 product after receiving $34.6 million from the U.S. Department of Defense. Emergent BioSolutions will collaborate with the Mount Sinai Health System, based in New York City, and ImmunoTek Bio Centers, based in Louisiana, to develop, manufacture and evaluate Emergent’s hyperimmune globulin product, COVID-HIG, for post-exposure prophylaxis of COVID-19 in frontline health-care workers. Funding for this collaboration came from DOD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. (Daily Record)

Read Full Article

Baltimore’s Hippodrome Theatre cancels fall season of touring Broadway musicals, will reopen in 2021

The Hippodrome Theatre announced Wednesday that has canceled its fall season because of the coronavirus pandemic, but plans to resume presenting touring Broadway musicals in January. “The Baltimore arts community along with its residents has been tested in unprecedented ways during this pandemic and has shown its strength and resilience over the last few months,” Ron Legler, president of The Hippodrome Theatre, said in a news release. (Balt Sun)

Read Full Article

United says it may furlough as many as 36,000 workers because of pandemic losses

United Airlines announced Wednesday that despite receiving billions in federal aid, it may furlough nearly 36,000 employees Oct. 1, a scenario that one union official called a “gut punch.” The number represents nearly 40 percent of the Chicago-based airline's workforce. Government grants received through the $2 trillion coronavirus relief package known as the Cares Act require airlines to keep front-line workers on the job through Sept. 30. In addition to receiving $4.9 billion in government grants, United signed a letter of intent this week to accept roughly $4.5 billion in loans through the program. (Wash Post)

Read Full Article

Nautilus Solar expands Md. footprint, acquires 15.1 MW community solar portfolio

Nautilus Solar Energy LLC, a community solar owner and operator in Summit, New Jersey, announced Wednesday the acquisition of a 15.1 MW community solar development portfolio from Elkridge-based SGC Power (“SGC”), a full life-cycle set provider of products that help solar asset owners invest, build and operate projects which give great financial returns. (Daily Record)

Read Full Article

Md.’s MaxCyte signs commercial licensing agreement with Austrian biotech

MaxCyte Inc., a Gaithersburg cell-based therapies and life sciences company, signed a clinical and commercial licensing agreement Wednesday with Apeiron Biologics AG, a private biotechnology company specializing in the discovery, development and commercialization of novel immunotherapies for cancer and respiratory diseases. Apeiron will obtain non-exclusive clinical and commercial rights to use MaxCyte’s Flow Electroporation technology and ExPERT platform for the advancement of APN401, a siRNA-based cell therapy currently in clinical development for various solid tumors. In return, MaxCyte will receive undisclosed development and approval milestones and sales-based payments in addition to other licensing fees. (Daily Record)

Read Full Article